Table 2.
Variable | ESRD (n = 200) | LVH Only (n = 30) |
---|---|---|
MTWA abnormala | 115 (57.5) | 8 (26.7) |
Age (years) | 56.3 (12.7) | 53.1 (10.7) |
Male (%) | 142 (71) | 25 (83.3) |
BMI (kg/m2) | 26.5 (4.7) | 27.1 (4.9) |
Systolic BP (mmHg) | 146 (24.1) | 152 (22.5) |
Diastolic BP (mmHg)a | 82 (14.2) | 89 (11.1) |
Diabetes mellitus | 54 (27.0) | 0 |
IHD | 49 (24.5) | 2 (9.5) |
Heart failure | 15 (7.5) | 1 (3.3) |
Cerebrovascular disease | 26 (13) | 1 (3.3) |
Peripheral vascular disease | 35 (17.5) | 0 |
Dyslipidemia | 117 (58.5) | 10 (33.3) |
Smoking | ||
never | 89 (44.5) | 19 (61.9) |
current/former | 111 (55.5) | 11 (38.1) |
Epo receptor agonist | 162 (81.0) | 0 |
β-Adrenoceptor blocker | 92 (46.0) | 10 (33.3) |
Aspirin | 102 (51.0) | 3 (10) |
Warfarin | 13 (6.5) | 0 |
Clopidogrel | 17 (8.5) | 0 |
ACEI/ARB | 91 (45.5) | 12 (40.0) |
Diuretic | 58 (29) | 6 (20.0) |
Nitrate | 15 (7.5) | 8 (26.7) |
Calcium channel blocker | 76 (38.0) | 8 (26.7) |
α-Adrenoceptor blocker | 24 (12.0) | 1 (3.3) |
Statin | 125 (62.5) | 9 (30.0) |
Hemoglobin (g/dl) | 11.4 (1.8) | 11.4 (1.8) |
ESR (mm/h) | 29 (9.5, 49.0) | 31 (14.5, 44.0) |
CRP (mg/L) | 4.9 (2.0, 9.9) | 5.0 (3.2, 16.0) |
Potassium (mmol/L) | 4.7 (0.7) | 4.7 (0.8) |
Adjusted calcium (mmol/L) | 2.39 (0.3) | 2.41 (0.1) |
Phosphate (mmol/L)a | 1.61 (0.5) | 1.10 (0.1) |
Glucose (mmol/L) | 5.5 (4.7, 7.7) | 5.1 (4.6, 6.1) |
CMR results | ||
EF (%) | 61.9 (15.3) | 65.8 (11.5) |
myocardial mass/BSA (g/m2) | 93.3 (38.2) | 82.0 (32.9) |
EDV/BSA (ml/m2 ) | 68.9 (35.6) | 67.1 (13.7) |
ESV/BSA (ml/m2 ) | 28.7 (26.2) | 23.5 (12.4) |
LVH on MRI | 124 (62.0) | 18 (60.0) |
LVSD on MRI (EF < 55%) | 45 (22.5) | 4 (13.8) |
LV dilation | 19 (9.5) | 2 (6.9) |
Data are number with percentage in parentheses or mean ± SD except for ESR, CRP, and glucose, where median and interquartile range are shown. Tests of significance are t test, χ2, or Fischer exact test as appropriate.
P < 0.05.